China Pharma Holdings (CPHI) Enterprise Value: 2009-2025
Historic Enterprise Value for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to $6.1 million.
- China Pharma Holdings' Enterprise Value rose 81.63% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 1213.05%. This contributed to the annual value of $3.8 million for FY2024, which is 50.18% up from last year.
- Per China Pharma Holdings' latest filing, its Enterprise Value stood at $6.1 million for Q3 2025, which was up 16.24% from $5.2 million recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Enterprise Value ranged from a high of $37.8 million in Q1 2021 and a low of $322,183 during Q3 2023.
- Moreover, its 3-year median value for Enterprise Value was $3.2 million (2024), whereas its average is $3.5 million.
- Per our database at Business Quant, China Pharma Holdings' Enterprise Value crashed by 92.77% in 2023 and then spiked by 935.71% in 2024.
- China Pharma Holdings' Enterprise Value (Quarterly) stood at $18.0 million in 2021, then crashed by 83.75% to $2.9 million in 2022, then decreased by 12.29% to $2.6 million in 2023, then skyrocketed by 50.18% to $3.8 million in 2024, then spiked by 81.63% to $6.1 million in 2025.
- Its Enterprise Value was $6.1 million in Q3 2025, compared to $5.2 million in Q2 2025 and $8.2 million in Q1 2025.